Lytenava 25 mg / mL solution for injection

Licence status
Authorised: 27/05/2024
Active substances
Bevacizumab
Dosage Form
Solution for injection
Licence number
EU/1/24/1798/001
Licence holder
Outlook Therapeutics NL B.V.

Product documents

Licence information

ATC code
S01LA08 bevacizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
27/05/2024